Regulation of haem biosynthesis in normoblastic erythropoiesis: role of 5-aminolaevulinic acid synthase and ferrochelatase.
The development of haem biosynthetic enzyme activity during normoblastic human erythropoiesis was examined in seven patients. The first and last enzymes of the haem biosynthetic pathway, ALA synthase and ferrochelatase, were assayed by radiochemical/high performance liquid chromatographic (HPLC) methods. An assay for ferrochelatase activity in human bone marrow was developed. Enzyme substrates were protoporphyrin IX and 59Fe2+ ions. 59Fe-labelled haem was isolated by organic solvent extraction/sorbent extraction followed by reversed-phase HPLC. Optimal activity occurred at pH 7.3 in the presence of ascorbic acid, in darkness and under anaerobic conditions. Haem production was proportional to cell number and was linear with time to 30 min. The assay was sensitive to the picomolar range of haem production. ALA synthase and ferrochelatase activity was assayed in four highly purified age-matched erythroid cell populations. ALA synthase activity was maximal in the most immature erythroid cells and diminished as the cells matured with an overall five fold loss of activity from proerythroblast to late erythroblast development. Ferrochelatase activity was, however, more stable with less than a two fold change in activity observed during the same period of erythroid differentiation. Maximal activity occurred in erythroid fractions enriched with intermediate erythroblasts. These results support sequential rather than simultaneous appearance of these enzymes during normoblastic erythropoiesis. Quantitative analysis of relative enzyme activity however indicates that at all times during erythroid differentiation ferrochelatase activity is present in excess to that theoretically required relative to ALA synthase activity since ALA and haem are not produced in stoichiometric amounts. The lability of ALA synthase versus the stability and gross relative excess of ferrochelatase activity indicates a far greater role for ALA synthase in the regulation of erythroid haem biosynthesis than for ferrochelatase.
Houston
T
T
Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK.
Moore
M R
MR
McColl
K E
KE
Fitzsimons
E J
EJ
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism*; D001853:Bone Marrow / Q000201:enzymology; D002454:Cell Differentiation; D004900:Erythroblasts / Q000201:enzymology*; D004920:Erythropoiesis; D005294:Ferrochelatase / Q000378:metabolism*; D006418:Heme / Q000096:biosynthesis* / Q000302:isolation & purification; D006801:Humans; D007504:Iron Radioisotopes
D007504:Iron Radioisotopes; D006418:Heme; D000624:5-Aminolevulinate Synthetase; D005294:Ferrochelatase